• Publications
  • Influence
Clinical practice guideline on diagnosis and treatment of hyponatraemia.
Hyponatraemia, defined as a serum sodium concentration <135 mmol/l, is the most common disorder of body fluid and electrolyte balance encountered in clinical practice. It can lead to a wide spectrumExpand
  • 598
  • 57
  • PDF
A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.
BACKGROUND Lanthanum carbonate (LC) (Fosrenol) is a novel new treatment for hyperphosphatemia. In this phase III, open-label study, we compared the effects of LC and calcium carbonate (CC) on theExpand
  • 302
  • 11
  • PDF
Chronic kidney disease as cause of cardiovascular morbidity and mortality.
To make an evidence-based evaluation of the relationship between kidney failure and cardiovascular risk, we reviewed the literature obtained from a PubMed search using pre-defined keywords related toExpand
  • 522
  • 9
  • PDF
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.
Under the auspices of the European Renal Best Practice, a group of European nephrologists, not serving on the Kidney Disease Improving Global Outcomes (KDIGO) working group, but with significantExpand
  • 98
  • 6
  • PDF
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care.
The European Best Practice Guideline group (EBPG) issued guidelines on the evaluation and selection of kidney donor and kidney transplant candidates, as well as post-transplant recipient care, in theExpand
  • 147
  • 5
  • PDF
Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
BACKGROUND Various biochemical markers have been evaluated in dialysis patients for the diagnosis of renal osteodystrophy (ROD). However, their value in predialysis patients with end-stage renalExpand
  • 105
  • 4
Quality of sleep in patients undergoing hemodialysis
BackgroundSleeping problems are common in hemodialysis (HD) patients. The aim of this study was to determine sleep quality (SQ) in HD patients and to evaluate its relationship with patient’s qualityExpand
  • 56
  • 4
Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease
Renal disorders account for a substantial fraction of the budget for health care in many countries. Proteinuria is a frequent manifestation in afflicted patients, but the origin of the proteinsExpand
  • 51
  • 3
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.
BACKGROUND Lanthanum carbonate (LC) has been proposed as a new phosphate binder. Presented here are the results from one centre that participated in a multicentre trial to assess the effect ofExpand
  • 137
  • 2
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.
Progressive CKD is generally detected at a late stage by a sustained decline in eGFR and/or the presence of significant albuminuria. With the aim of early and improved risk stratification of patientsExpand
  • 141
  • 2
  • PDF